FDA Approves Onfi to Treat Severe Seizures
Drug Alerts , News / September 27, 2016

On October 21st, the FDA approved Onfi tablets (clobazam) for use an adjunct treatment for seizures associated with Lennox-Gastaut syndrome in adults and children 2 years of age and older. Lennox-Gastaut syndrome is a severe form of epilepsy that ...

Skip to toolbar